Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 296

1.

Dynamic contrast-enhanced MR imaging in the evaluation of patients with prostate cancer.

McMahon CJ, Bloch BN, Lenkinski RE, Rofsky NM.

Magn Reson Imaging Clin N Am. 2009 May;17(2):363-83. doi: 10.1016/j.mric.2009.01.013. Review.

PMID:
19406364
2.

[MR techniques for noninvasive diagnosis of prostate cancer].

Morakkabati-Spitz N, Bastian PJ, Meissner A, Träber F, Gieseke J, Schild HH, Müller SC.

Urologe A. 2006 Jun;45(6):702-5. German.

PMID:
16788787
3.

Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer.

Kayhan A, Fan X, Oto A.

Top Magn Reson Imaging. 2009 Apr;20(2):105-12. doi: 10.1097/RMR.0b013e3181c0e2fa. Review.

PMID:
20010065
4.

Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.

Carlani M, Mancino S, Bonanno E, Finazzi Agrò E, Simonetti G.

Radiol Med. 2008 Aug;113(5):670-88. doi: 10.1007/s11547-008-0271-8. Epub 2008 May 20. English, Italian.

PMID:
18493829
5.

Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.

Franiel T, Lüdemann L, Rudolph B, Rehbein H, Staack A, Taupitz M, Prochnow D, Beyersdorff D.

Invest Radiol. 2008 Jul;43(7):481-7. doi: 10.1097/RLI.0b013e31816b2f63.

PMID:
18580330
6.

[Multiparametric magnetic resonance imaging of the prostate - technique and clinical applications].

Franiel T.

Rofo. 2011 Jul;183(7):607-17. doi: 10.1055/s-0029-1246055. Epub 2011 Apr 12. Review. German.

PMID:
21487980
7.

The value of dynamic MR imaging for hypointensity lesions of the peripheral zone of the prostate.

Namimoto T, Morishita S, Saitoh R, Kudoh J, Yamashita Y, Takahashi M.

Comput Med Imaging Graph. 1998 May-Jun;22(3):239-45.

PMID:
9740041
8.

Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer.

Barentsz JO, Engelbrecht M, Jager GJ, Witjes JA, de LaRosette J, van Der Sanden BP, Huisman HJ, Heerschap A.

J Magn Reson Imaging. 1999 Sep;10(3):295-304. Review.

PMID:
10508289
9.

Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device.

Engelhard K, Hollenbach HP, Kiefer B, Winkel A, Goeb K, Engehausen D.

Eur Radiol. 2006 Jun;16(6):1237-43. Epub 2006 Feb 1.

PMID:
16447048
10.

[Multiparametric MRI of the prostate: method for early detection of prostate cancer?].

Schlemmer HP.

Rofo. 2010 Dec;182(12):1067-75. doi: 10.1055/s-0029-1245786. Epub 2010 Oct 22. Review. German.

PMID:
20972932
11.

Initial experience of 3 tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostate.

Fütterer JJ, Scheenen TW, Huisman HJ, Klomp DW, van Dorsten FA, Hulsbergen-van de Kaa CA, Witjes JA, Heerschap A, Barentsz JO.

Invest Radiol. 2004 Nov;39(11):671-80.

PMID:
15486528
12.

Dynamic contrast-enhanced magnetic resonance imaging in the evaluation of the prostate.

Bonekamp D, Macura KJ.

Top Magn Reson Imaging. 2008 Dec;19(6):273-84. doi: 10.1097/RMR.0b013e3181aacdc2. Review.

PMID:
19512849
13.

[MR detection of local prostate cancer recurrence after transrectal high-intensity focused US treatment: preliminary results].

Ben Cheikh A, Girouin N, Ryon-Taponnier P, Mège-Lechevallier F, Gelet A, Chapelon JY, Lyonnet D, Rouvière O.

J Radiol. 2008 May;89(5 Pt 1):571-7. French.

14.

MR imaging and MR spectroscopy in prostate cancer management.

Katz S, Rosen M.

Radiol Clin North Am. 2006 Sep;44(5):723-34, viii. Review.

PMID:
17030223
15.

Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA.

Padhani AR, Gapinski CJ, Macvicar DA, Parker GJ, Suckling J, Revell PB, Leach MO, Dearnaley DP, Husband JE.

Clin Radiol. 2000 Feb;55(2):99-109.

PMID:
10657154
16.

3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils; Initial experience(1).

Bloch BN, Rofsky NM, Baroni RH, Marquis RP, Pedrosa I, Lenkinski RE.

Acad Radiol. 2004 Aug;11(8):863-7.

PMID:
15288036
17.

Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.

Haider MA, Chung P, Sweet J, Toi A, Jhaveri K, Ménard C, Warde P, Trachtenberg J, Lockwood G, Milosevic M.

Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):425-30. Epub 2007 Sep 19.

PMID:
17881141
18.

[Pharmacokinetic MRI of the prostate: parameters for differentiating low-grade and high-grade prostate cancer].

Franiel T, Lüdemann L, Taupitz M, Rost J, Asbach P, Beyersdorff D.

Rofo. 2009 Jun;181(6):536-42. doi: 10.1055/s-0028-1109168. Epub 2009 Apr 7. German. Erratum in: Rofo. 2009 Jul;181(7):657.

PMID:
19353483
19.

MR imaging and MR spectroscopic imaging of prostate cancer.

Rajesh A, Coakley FV.

Magn Reson Imaging Clin N Am. 2004 Aug;12(3):557-79, vii. Review.

PMID:
15271371
20.

MRI of the prostate: clinical relevance and emerging applications.

Mazaheri Y, Shukla-Dave A, Muellner A, Hricak H.

J Magn Reson Imaging. 2011 Feb;33(2):258-74. doi: 10.1002/jmri.22420. Review.

PMID:
21274967
Items per page

Supplemental Content

Write to the Help Desk